The role of stem cells in pediatric central nervous system malignancies

7Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Representing the leading cause of childhood cancer mortality, pediatric brain tumors are comprised of diverse histological features, genetic perturbations, cellular populations, treatment protocols, and clinical outcomes. In this chapter we discuss recent and emerging data that implicate cancer stem cells (also known as brain tumor-initiating cells) in initiating and maintaining the growth of a number of pediatric brain tumors including: medulloblastoma, supratentorial primitive  neuroectodermal tumor, atypical teratoid/rhabdoid tumor, ependymoma, low-grade glioma, glioblastoma, diffuse intrinsic pontine glioma, germ cell tumor, and craniopharyngioma. The development of a stem cell framework for the study and treatment of these tumors will enable future clinical approaches to harness the heterogeneous cellular and genomic landscape of these solid tumors as an avenue for developing targeted patient-oriented therapies, thereby improving the overall survivorship for the most lethal childhood cancer.

Cite

CITATION STYLE

APA

Manoranjan, B., Garg, N., Bakhshinyan, D., & Singh, S. K. (2015). The role of stem cells in pediatric central nervous system malignancies. Advances in Experimental Medicine and Biology, 853, 49–68. https://doi.org/10.1007/978-3-319-16537-0_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free